2023-2029 Global TCR Based Therapy Industry Research & Trends Analysis Report
2023-2029 Global TCR Based Therapy Industry Research & Trends Analysis Report
Analysis of the TCR Based Therapy Market reveals emerging trends, consumer adoption rates, and competitive strategies among leading manufacturers worldwide.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to Latest Research, the global market for TCR Based Therapy should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China TCR Based Therapy market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States TCR Based Therapy market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Transduction of Chimeric Antigen Receptor segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospitals has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of TCR Based Therapy include Adaptimmune Therapeutics, Alaunos Therapeutics, Bristol Myers Squibb, Cellular Biomedicine, Gilead Biosciences, GlaxoSmithKline, Immatics, Immunocore and Lion TCR, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for TCR Based Therapy. Report Highlights:
(1) Global TCR Based Therapy market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global TCR Based Therapy market competitive situation, revenue and market share, from 2018 to 2022.
(3) China TCR Based Therapy market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global TCR Based Therapy segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global TCR Based Therapy segment by type and by application and regional segment by type and by application.
(6) TCR Based Therapy industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Transduction of Chimeric Antigen Receptor
Transduction of TCR α/β Heterodimer
Market segment by application, can be divided into
Hospitals
Clinics & Ambulatory Centers
Cancer Research Institutes
Others
Market segment by players, this report covers
Adaptimmune Therapeutics
Alaunos Therapeutics
Bristol Myers Squibb
Cellular Biomedicine
Gilead Biosciences
GlaxoSmithKline
Immatics
Immunocore
Lion TCR
Takara Bio
Zelluna Immunotherapy
1 Market Overview
1.1 Product Overview and Scope of TCR Based Therapy
1.2 Global TCR Based Therapy Market Size and Forecast
1.3 China TCR Based Therapy Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China TCR Based Therapy Share in Global Market, 2018-2029
1.4.2 TCR Based Therapy Market Size: China VS Global, 2018-2029
1.5 TCR Based Therapy Market Dynamics
1.5.1 TCR Based Therapy Market Drivers
1.5.2 TCR Based Therapy Market Restraints
1.5.3 TCR Based Therapy Industry Trends
1.5.4 TCR Based Therapy Industry Policy
2 Global Competitive Situation by Company
2.1 Global TCR Based Therapy Revenue by Company (2018-2023)
2.2 Global TCR Based Therapy Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global TCR Based Therapy Concentration Ratio
2.4 Global TCR Based Therapy Mergers & Acquisitions, Expansion Plans
2.5 Global TCR Based Therapy Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China TCR Based Therapy Revenue by Company (2018-2023)
3.2 China TCR Based Therapy TCR Based Therapy Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China TCR Based Therapy, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 TCR Based Therapy Industry Chain
4.2 TCR Based Therapy Upstream Analysis
4.3 TCR Based Therapy Midstream Analysis
4.4 TCR Based Therapy Downstream Analysis
5 Sights by Type
5.1 TCR Based Therapy Classification
5.1.1 Transduction of Chimeric Antigen Receptor
5.1.2 Transduction of TCR α/β Heterodimer
5.2 By Type, Global TCR Based Therapy Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global TCR Based Therapy Revenue, 2018-2029
6 Sights by Application
6.1 TCR Based Therapy Segment by Application
6.1.1 Hospitals
6.1.2 Clinics & Ambulatory Centers
6.1.3 Cancer Research Institutes
6.1.4 Others
6.2 By Application, Global TCR Based Therapy Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global TCR Based Therapy Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global TCR Based Therapy Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global TCR Based Therapy Market Size, 2018-2029
7.3 North America
7.3.1 North America TCR Based Therapy Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America TCR Based Therapy Market Size Market Share
7.4 Europe
7.4.1 Europe TCR Based Therapy Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe TCR Based Therapy Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific TCR Based Therapy Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific TCR Based Therapy Market Size Market Share
7.6 South America
7.6.1 South America TCR Based Therapy Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America TCR Based Therapy Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global TCR Based Therapy Market Size & CAGR，2018 VS 2022 VS 2029
8.2 By Country, Global TCR Based Therapy Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. TCR Based Therapy Market Size, 2018-2029
8.3.2 By Company, U.S. TCR Based Therapy Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. TCR Based Therapy Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. TCR Based Therapy Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe TCR Based Therapy Market Size, 2018-2029
8.4.2 By Company, Europe TCR Based Therapy Revenue Market Share, 2018-2023
8.4.3 By Type, Europe TCR Based Therapy Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe TCR Based Therapy Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China TCR Based Therapy Market Size, 2018-2029
8.5.2 By Company, China TCR Based Therapy Revenue Market Share, 2018-2023
8.5.3 By Type, China TCR Based Therapy Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China TCR Based Therapy Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan TCR Based Therapy Market Size, 2018-2029
8.6.2 By Company, Japan TCR Based Therapy Revenue Market Share, 2018-2023
8.6.3 By Type, Japan TCR Based Therapy Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan TCR Based Therapy Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea TCR Based Therapy Market Size, 2018-2029
8.7.2 By Company, South Korea TCR Based Therapy Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea TCR Based Therapy Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea TCR Based Therapy Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia TCR Based Therapy Market Size, 2018-2029
8.8.2 By Company, Southeast Asia TCR Based Therapy Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia TCR Based Therapy Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia TCR Based Therapy Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India TCR Based Therapy Market Size, 2018-2029
8.9.2 By Company, India TCR Based Therapy Revenue Market Share, 2018-2023
8.9.3 By Type, India TCR Based Therapy Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India TCR Based Therapy Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia TCR Based Therapy Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia TCR Based Therapy Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia TCR Based Therapy Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia TCR Based Therapy Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Adaptimmune Therapeutics
9.1.1 Adaptimmune Therapeutics Company Information, Head Office, Market Area and Industry Position
9.1.2 Adaptimmune Therapeutics Company Profile and Main Business
9.1.3 Adaptimmune Therapeutics TCR Based Therapy Models, Specifications and Application
9.1.4 Adaptimmune Therapeutics TCR Based Therapy Revenue and Gross Margin, 2018-2023
9.1.5 Adaptimmune Therapeutics Recent Developments
9.2 Alaunos Therapeutics
9.2.1 Alaunos Therapeutics Company Information, Head Office, Market Area and Industry Position
9.2.2 Alaunos Therapeutics Company Profile and Main Business
9.2.3 Alaunos Therapeutics TCR Based Therapy Models, Specifications and Application
9.2.4 Alaunos Therapeutics TCR Based Therapy Revenue and Gross Margin, 2018-2023
9.2.5 Alaunos Therapeutics Recent Developments
9.3 Bristol Myers Squibb
9.3.1 Bristol Myers Squibb Company Information, Head Office, Market Area and Industry Position
9.3.2 Bristol Myers Squibb Company Profile and Main Business
9.3.3 Bristol Myers Squibb TCR Based Therapy Models, Specifications and Application
9.3.4 Bristol Myers Squibb TCR Based Therapy Revenue and Gross Margin, 2018-2023
9.3.5 Bristol Myers Squibb Recent Developments
9.4 Cellular Biomedicine
9.4.1 Cellular Biomedicine Company Information, Head Office, Market Area and Industry Position
9.4.2 Cellular Biomedicine Company Profile and Main Business
9.4.3 Cellular Biomedicine TCR Based Therapy Models, Specifications and Application
9.4.4 Cellular Biomedicine TCR Based Therapy Revenue and Gross Margin, 2018-2023
9.4.5 Cellular Biomedicine Recent Developments
9.5 Gilead Biosciences
9.5.1 Gilead Biosciences Company Information, Head Office, Market Area and Industry Position
9.5.2 Gilead Biosciences Company Profile and Main Business
9.5.3 Gilead Biosciences TCR Based Therapy Models, Specifications and Application
9.5.4 Gilead Biosciences TCR Based Therapy Revenue and Gross Margin, 2018-2023
9.5.5 Gilead Biosciences Recent Developments
9.6 GlaxoSmithKline
9.6.1 GlaxoSmithKline Company Information, Head Office, Market Area and Industry Position
9.6.2 GlaxoSmithKline Company Profile and Main Business
9.6.3 GlaxoSmithKline TCR Based Therapy Models, Specifications and Application
9.6.4 GlaxoSmithKline TCR Based Therapy Revenue and Gross Margin, 2018-2023
9.6.5 GlaxoSmithKline Recent Developments
9.7 Immatics
9.7.1 Immatics Company Information, Head Office, Market Area and Industry Position
9.7.2 Immatics Company Profile and Main Business
9.7.3 Immatics TCR Based Therapy Models, Specifications and Application
9.7.4 Immatics TCR Based Therapy Revenue and Gross Margin, 2018-2023
9.7.5 Immatics Recent Developments
9.8 Immunocore
9.8.1 Immunocore Company Information, Head Office, Market Area and Industry Position
9.8.2 Immunocore Company Profile and Main Business
9.8.3 Immunocore TCR Based Therapy Models, Specifications and Application
9.8.4 Immunocore TCR Based Therapy Revenue and Gross Margin, 2018-2023
9.8.5 Immunocore Recent Developments
9.9 Lion TCR
9.9.1 Lion TCR Company Information, Head Office, Market Area and Industry Position
9.9.2 Lion TCR Company Profile and Main Business
9.9.3 Lion TCR TCR Based Therapy Models, Specifications and Application
9.9.4 Lion TCR TCR Based Therapy Revenue and Gross Margin, 2018-2023
9.9.5 Lion TCR Recent Developments
9.10 Takara Bio
9.10.1 Takara Bio Company Information, Head Office, Market Area and Industry Position
9.10.2 Takara Bio Company Profile and Main Business
9.10.3 Takara Bio TCR Based Therapy Models, Specifications and Application
9.10.4 Takara Bio TCR Based Therapy Revenue and Gross Margin, 2018-2023
9.10.5 Takara Bio Recent Developments
9.11 Zelluna Immunotherapy
9.11.1 Zelluna Immunotherapy Company Information, Head Office, Market Area and Industry Position
9.11.2 Zelluna Immunotherapy Company Profile and Main Business
9.11.3 Zelluna Immunotherapy TCR Based Therapy Models, Specifications and Application
9.11.4 Zelluna Immunotherapy TCR Based Therapy Revenue and Gross Margin, 2018-2023
9.11.5 Zelluna Immunotherapy Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Table 1. TCR Based Therapy Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. TCR Based Therapy Market Restraints
Table 3. TCR Based Therapy Market Trends
Table 4. TCR Based Therapy Industry Policy
Table 5. Global TCR Based Therapy Revenue by Company (2018-2023) & (US$ million)
Table 6. Global TCR Based Therapy Revenue Market Share by Company (2018-2023)
Table 7. Global TCR Based Therapy Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global TCR Based Therapy Mergers & Acquisitions, Expansion Plans
Table 9. Global TCR Based Therapy Manufacturers Product Type
Table 10. China TCR Based Therapy Revenue by Company (2018-2023) & (US$ million)
Table 11. China TCR Based Therapy Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of TCR Based Therapy Upstream (Raw Materials)
Table 13. Global TCR Based Therapy Typical Customers
Table 14. TCR Based Therapy Typical Distributors
Table 15. By Type, Global TCR Based Therapy Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global TCR Based Therapy Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global TCR Based Therapy Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global TCR Based Therapy Revenue, 2018-2029, US$ Million
Table 19. By Country, Global TCR Based Therapy Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global TCR Based Therapy Revenue, 2018-2029, US$ Million
Table 21. By Country, Global TCR Based Therapy Revenue Market Share, 2018-2029
Table 22. Adaptimmune Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 23. Adaptimmune Therapeutics Company Profile and Main Business
Table 24. Adaptimmune Therapeutics TCR Based Therapy Models, Specifications and Application
Table 25. Adaptimmune Therapeutics TCR Based Therapy Revenue and Gross Margin, 2018-2023
Table 26. Adaptimmune Therapeutics Recent Developments
Table 27. Alaunos Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 28. Alaunos Therapeutics Company Profile and Main Business
Table 29. Alaunos Therapeutics TCR Based Therapy Models, Specifications and Application
Table 30. Alaunos Therapeutics TCR Based Therapy Revenue and Gross Margin, 2018-2023
Table 31. Alaunos Therapeutics Recent Developments
Table 32. Bristol Myers Squibb Company Information, Head Office, Market Area and Industry Position
Table 33. Bristol Myers Squibb Company Profile and Main Business
Table 34. Bristol Myers Squibb TCR Based Therapy Models, Specifications and Application
Table 35. Bristol Myers Squibb TCR Based Therapy Revenue and Gross Margin, 2018-2023
Table 36. Bristol Myers Squibb Recent Developments
Table 37. Cellular Biomedicine Company Information, Head Office, Market Area and Industry Position
Table 38. Cellular Biomedicine Company Profile and Main Business
Table 39. Cellular Biomedicine TCR Based Therapy Models, Specifications and Application
Table 40. Cellular Biomedicine TCR Based Therapy Revenue and Gross Margin, 2018-2023
Table 41. Cellular Biomedicine Recent Developments
Table 42. Gilead Biosciences Company Information, Head Office, Market Area and Industry Position
Table 43. Gilead Biosciences Company Profile and Main Business
Table 44. Gilead Biosciences TCR Based Therapy Models, Specifications and Application
Table 45. Gilead Biosciences TCR Based Therapy Revenue and Gross Margin, 2018-2023
Table 46. Gilead Biosciences Recent Developments
Table 47. GlaxoSmithKline Company Information, Head Office, Market Area and Industry Position
Table 48. GlaxoSmithKline Company Profile and Main Business
Table 49. GlaxoSmithKline TCR Based Therapy Models, Specifications and Application
Table 50. GlaxoSmithKline TCR Based Therapy Revenue and Gross Margin, 2018-2023
Table 51. GlaxoSmithKline Recent Developments
Table 52. Immatics Company Information, Head Office, Market Area and Industry Position
Table 53. Immatics Company Profile and Main Business
Table 54. Immatics TCR Based Therapy Models, Specifications and Application
Table 55. Immatics TCR Based Therapy Revenue and Gross Margin, 2018-2023
Table 56. Immatics Recent Developments
Table 57. Immunocore Company Information, Head Office, Market Area and Industry Position
Table 58. Immunocore Company Profile and Main Business
Table 59. Immunocore TCR Based Therapy Models, Specifications and Application
Table 60. Immunocore TCR Based Therapy Revenue and Gross Margin, 2018-2023
Table 61. Immunocore Recent Developments
Table 62. Lion TCR Company Information, Head Office, Market Area and Industry Position
Table 63. Lion TCR Company Profile and Main Business
Table 64. Lion TCR TCR Based Therapy Models, Specifications and Application
Table 65. Lion TCR TCR Based Therapy Revenue and Gross Margin, 2018-2023
Table 66. Lion TCR Recent Developments
Table 67. Takara Bio Company Information, Head Office, Market Area and Industry Position
Table 68. Takara Bio Company Profile and Main Business
Table 69. Takara Bio TCR Based Therapy Models, Specifications and Application
Table 70. Takara Bio TCR Based Therapy Revenue and Gross Margin, 2018-2023
Table 71. Takara Bio Recent Developments
Table 72. Zelluna Immunotherapy Company Information, Head Office, Market Area and Industry Position
Table 73. Zelluna Immunotherapy Company Profile and Main Business
Table 74. Zelluna Immunotherapy TCR Based Therapy Models, Specifications and Application
Table 75. Zelluna Immunotherapy TCR Based Therapy Revenue and Gross Margin, 2018-2023
Table 76. Zelluna Immunotherapy Recent Developments
List of Figure
Figure 1. TCR Based Therapy Picture
Figure 2. Global TCR Based Therapy Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China TCR Based Therapy Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China TCR Based Therapy Market Share of Global
Figure 5. Global TCR Based Therapy Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global TCR Based Therapy Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China TCR Based Therapy Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China TCR Based Therapy Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. TCR Based Therapy Industry Chain
Figure 10. Transduction of Chimeric Antigen Receptor
Figure 11. Transduction of TCR α/β Heterodimer
Figure 12. By Type, Global TCR Based Therapy Revenue, 2018-2029, US$ Million
Figure 13. By Type, Global TCR Based Therapy Revenue Market Share, 2018-2029
Figure 14. Hospitals
Figure 15. Clinics & Ambulatory Centers
Figure 16. Cancer Research Institutes
Figure 17. Others
Figure 18. By Application, Global TCR Based Therapy Revenue, 2018-2029, US$ Million
Figure 19. By Application, Global TCR Based Therapy Revenue Market Share, 2018-2029
Figure 20. By Region, Global TCR Based Therapy Revenue Market Share, 2018-2029
Figure 21. North America TCR Based Therapy Revenue & Forecasts, 2018-2029, US$ Million
Figure 22. By Country, North America TCR Based Therapy Revenue Market Share, 2018-2023
Figure 23. Europe TCR Based Therapy Revenue & Forecasts, 2018-2029, US$ Million
Figure 24. By Country, Europe TCR Based Therapy Revenue Market Share, 2018-2023
Figure 25. Asia Pacific TCR Based Therapy Revenue & Forecasts, 2018-2029, US$ Million
Figure 26. By Country/Region, Asia Pacific TCR Based Therapy Revenue Market Share, 2018-2023
Figure 27. South America TCR Based Therapy Revenue & Forecasts, 2018-2029, US$ Million
Figure 28. By Country, South America TCR Based Therapy Revenue Market Share, 2018-2023
Figure 29. Middle East & Africa TCR Based Therapy Revenue & Forecasts, 2018-2029, US$ Million
Figure 30. U.S. TCR Based Therapy Revenue, 2018-2029, (US$ Million)
Figure 31. By Company, U.S. TCR Based Therapy Market Share, 2018-2023
Figure 32. By Type, U.S. TCR Based Therapy Revenue Market Share, 2022 VS 2029
Figure 33. By Application, U.S. TCR Based Therapy Revenue Market Share, 2022 VS 2029
Figure 34. Europe TCR Based Therapy Revenue, 2018-2029, (US$ Million)
Figure 35. By Company, Europe TCR Based Therapy Market Share, 2018-2023
Figure 36. By Type, Europe TCR Based Therapy Revenue Market Share, 2022 VS 2029
Figure 37. By Application, Europe TCR Based Therapy Revenue Market Share, 2022 VS 2029
Figure 38. China TCR Based Therapy Revenue, 2018-2029, (US$ Million)
Figure 39. By Company, China TCR Based Therapy Market Share, 2018-2023
Figure 40. By Type, China TCR Based Therapy Revenue Market Share, 2022 VS 2029
Figure 41. By Application, China TCR Based Therapy Revenue Market Share, 2022 VS 2029
Figure 42. Japan TCR Based Therapy Revenue, 2018-2029, (US$ Million)
Figure 43. By Company, Japan TCR Based Therapy Market Share, 2018-2023
Figure 44. By Type, Japan TCR Based Therapy Revenue Market Share, 2022 VS 2029
Figure 45. By Application, Japan TCR Based Therapy Revenue Market Share, 2022 VS 2029
Figure 46. South Korea TCR Based Therapy Revenue, 2018-2029, (US$ Million)
Figure 47. By Company, South Korea TCR Based Therapy Market Share, 2018-2023
Figure 48. By Type, South Korea TCR Based Therapy Revenue Market Share, 2022 VS 2029
Figure 49. By Application, South Korea TCR Based Therapy Revenue Market Share, 2022 VS 2029
Figure 50. Southeast Asia TCR Based Therapy Revenue, 2018-2029, (US$ Million)
Figure 51. By Company, Southeast Asia TCR Based Therapy Market Share, 2018-2023
Figure 52. By Type, Southeast Asia TCR Based Therapy Revenue Market Share, 2022 VS 2029
Figure 53. By Application, Southeast Asia TCR Based Therapy Revenue Market Share, 2022 VS 2029
Figure 54. India TCR Based Therapy Revenue, 2018-2029, (US$ Million)
Figure 55. By Company, India TCR Based Therapy Market Share, 2018-2023
Figure 56. By Type, India TCR Based Therapy Revenue Market Share, 2022 VS 2029
Figure 57. By Application, India TCR Based Therapy Revenue Market Share, 2022 VS 2029
Figure 58. Middle East & Asia TCR Based Therapy Revenue, 2018-2029, (US$ Million)
Figure 59. By Company, Middle East & Asia TCR Based Therapy Market Share, 2018-2023
Figure 60. By Type, Middle East & Asia TCR Based Therapy Revenue Market Share, 2022 VS 2029
Figure 61. By Application, Middle East & Asia TCR Based Therapy Revenue Market Share, 2022 VS 2029
Figure 62. Research Methodology
Figure 63. Breakdown of Primary Interviews
Figure 64. Bottom-up Approaches
Figure 65. Top-down Approaches
Table 1. TCR Based Therapy Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. TCR Based Therapy Market Restraints
Table 3. TCR Based Therapy Market Trends
Table 4. TCR Based Therapy Industry Policy
Table 5. Global TCR Based Therapy Revenue by Company (2018-2023) & (US$ million)
Table 6. Global TCR Based Therapy Revenue Market Share by Company (2018-2023)
Table 7. Global TCR Based Therapy Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global TCR Based Therapy Mergers & Acquisitions, Expansion Plans
Table 9. Global TCR Based Therapy Manufacturers Product Type
Table 10. China TCR Based Therapy Revenue by Company (2018-2023) & (US$ million)
Table 11. China TCR Based Therapy Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of TCR Based Therapy Upstream (Raw Materials)
Table 13. Global TCR Based Therapy Typical Customers
Table 14. TCR Based Therapy Typical Distributors
Table 15. By Type, Global TCR Based Therapy Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global TCR Based Therapy Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global TCR Based Therapy Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global TCR Based Therapy Revenue, 2018-2029, US$ Million
Table 19. By Country, Global TCR Based Therapy Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global TCR Based Therapy Revenue, 2018-2029, US$ Million
Table 21. By Country, Global TCR Based Therapy Revenue Market Share, 2018-2029
Table 22. Adaptimmune Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 23. Adaptimmune Therapeutics Company Profile and Main Business
Table 24. Adaptimmune Therapeutics TCR Based Therapy Models, Specifications and Application
Table 25. Adaptimmune Therapeutics TCR Based Therapy Revenue and Gross Margin, 2018-2023
Table 26. Adaptimmune Therapeutics Recent Developments
Table 27. Alaunos Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 28. Alaunos Therapeutics Company Profile and Main Business
Table 29. Alaunos Therapeutics TCR Based Therapy Models, Specifications and Application
Table 30. Alaunos Therapeutics TCR Based Therapy Revenue and Gross Margin, 2018-2023
Table 31. Alaunos Therapeutics Recent Developments
Table 32. Bristol Myers Squibb Company Information, Head Office, Market Area and Industry Position
Table 33. Bristol Myers Squibb Company Profile and Main Business
Table 34. Bristol Myers Squibb TCR Based Therapy Models, Specifications and Application
Table 35. Bristol Myers Squibb TCR Based Therapy Revenue and Gross Margin, 2018-2023
Table 36. Bristol Myers Squibb Recent Developments
Table 37. Cellular Biomedicine Company Information, Head Office, Market Area and Industry Position
Table 38. Cellular Biomedicine Company Profile and Main Business
Table 39. Cellular Biomedicine TCR Based Therapy Models, Specifications and Application
Table 40. Cellular Biomedicine TCR Based Therapy Revenue and Gross Margin, 2018-2023
Table 41. Cellular Biomedicine Recent Developments
Table 42. Gilead Biosciences Company Information, Head Office, Market Area and Industry Position
Table 43. Gilead Biosciences Company Profile and Main Business
Table 44. Gilead Biosciences TCR Based Therapy Models, Specifications and Application
Table 45. Gilead Biosciences TCR Based Therapy Revenue and Gross Margin, 2018-2023
Table 46. Gilead Biosciences Recent Developments
Table 47. GlaxoSmithKline Company Information, Head Office, Market Area and Industry Position
Table 48. GlaxoSmithKline Company Profile and Main Business
Table 49. GlaxoSmithKline TCR Based Therapy Models, Specifications and Application
Table 50. GlaxoSmithKline TCR Based Therapy Revenue and Gross Margin, 2018-2023
Table 51. GlaxoSmithKline Recent Developments
Table 52. Immatics Company Information, Head Office, Market Area and Industry Position
Table 53. Immatics Company Profile and Main Business
Table 54. Immatics TCR Based Therapy Models, Specifications and Application
Table 55. Immatics TCR Based Therapy Revenue and Gross Margin, 2018-2023
Table 56. Immatics Recent Developments
Table 57. Immunocore Company Information, Head Office, Market Area and Industry Position
Table 58. Immunocore Company Profile and Main Business
Table 59. Immunocore TCR Based Therapy Models, Specifications and Application
Table 60. Immunocore TCR Based Therapy Revenue and Gross Margin, 2018-2023
Table 61. Immunocore Recent Developments
Table 62. Lion TCR Company Information, Head Office, Market Area and Industry Position
Table 63. Lion TCR Company Profile and Main Business
Table 64. Lion TCR TCR Based Therapy Models, Specifications and Application
Table 65. Lion TCR TCR Based Therapy Revenue and Gross Margin, 2018-2023
Table 66. Lion TCR Recent Developments
Table 67. Takara Bio Company Information, Head Office, Market Area and Industry Position
Table 68. Takara Bio Company Profile and Main Business
Table 69. Takara Bio TCR Based Therapy Models, Specifications and Application
Table 70. Takara Bio TCR Based Therapy Revenue and Gross Margin, 2018-2023
Table 71. Takara Bio Recent Developments
Table 72. Zelluna Immunotherapy Company Information, Head Office, Market Area and Industry Position
Table 73. Zelluna Immunotherapy Company Profile and Main Business
Table 74. Zelluna Immunotherapy TCR Based Therapy Models, Specifications and Application
Table 75. Zelluna Immunotherapy TCR Based Therapy Revenue and Gross Margin, 2018-2023
Table 76. Zelluna Immunotherapy Recent Developments
List of Figure
Figure 1. TCR Based Therapy Picture
Figure 2. Global TCR Based Therapy Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China TCR Based Therapy Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China TCR Based Therapy Market Share of Global
Figure 5. Global TCR Based Therapy Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global TCR Based Therapy Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China TCR Based Therapy Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China TCR Based Therapy Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. TCR Based Therapy Industry Chain
Figure 10. Transduction of Chimeric Antigen Receptor
Figure 11. Transduction of TCR α/β Heterodimer
Figure 12. By Type, Global TCR Based Therapy Revenue, 2018-2029, US$ Million
Figure 13. By Type, Global TCR Based Therapy Revenue Market Share, 2018-2029
Figure 14. Hospitals
Figure 15. Clinics & Ambulatory Centers
Figure 16. Cancer Research Institutes
Figure 17. Others
Figure 18. By Application, Global TCR Based Therapy Revenue, 2018-2029, US$ Million
Figure 19. By Application, Global TCR Based Therapy Revenue Market Share, 2018-2029
Figure 20. By Region, Global TCR Based Therapy Revenue Market Share, 2018-2029
Figure 21. North America TCR Based Therapy Revenue & Forecasts, 2018-2029, US$ Million
Figure 22. By Country, North America TCR Based Therapy Revenue Market Share, 2018-2023
Figure 23. Europe TCR Based Therapy Revenue & Forecasts, 2018-2029, US$ Million
Figure 24. By Country, Europe TCR Based Therapy Revenue Market Share, 2018-2023
Figure 25. Asia Pacific TCR Based Therapy Revenue & Forecasts, 2018-2029, US$ Million
Figure 26. By Country/Region, Asia Pacific TCR Based Therapy Revenue Market Share, 2018-2023
Figure 27. South America TCR Based Therapy Revenue & Forecasts, 2018-2029, US$ Million
Figure 28. By Country, South America TCR Based Therapy Revenue Market Share, 2018-2023
Figure 29. Middle East & Africa TCR Based Therapy Revenue & Forecasts, 2018-2029, US$ Million
Figure 30. U.S. TCR Based Therapy Revenue, 2018-2029, (US$ Million)
Figure 31. By Company, U.S. TCR Based Therapy Market Share, 2018-2023
Figure 32. By Type, U.S. TCR Based Therapy Revenue Market Share, 2022 VS 2029
Figure 33. By Application, U.S. TCR Based Therapy Revenue Market Share, 2022 VS 2029
Figure 34. Europe TCR Based Therapy Revenue, 2018-2029, (US$ Million)
Figure 35. By Company, Europe TCR Based Therapy Market Share, 2018-2023
Figure 36. By Type, Europe TCR Based Therapy Revenue Market Share, 2022 VS 2029
Figure 37. By Application, Europe TCR Based Therapy Revenue Market Share, 2022 VS 2029
Figure 38. China TCR Based Therapy Revenue, 2018-2029, (US$ Million)
Figure 39. By Company, China TCR Based Therapy Market Share, 2018-2023
Figure 40. By Type, China TCR Based Therapy Revenue Market Share, 2022 VS 2029
Figure 41. By Application, China TCR Based Therapy Revenue Market Share, 2022 VS 2029
Figure 42. Japan TCR Based Therapy Revenue, 2018-2029, (US$ Million)
Figure 43. By Company, Japan TCR Based Therapy Market Share, 2018-2023
Figure 44. By Type, Japan TCR Based Therapy Revenue Market Share, 2022 VS 2029
Figure 45. By Application, Japan TCR Based Therapy Revenue Market Share, 2022 VS 2029
Figure 46. South Korea TCR Based Therapy Revenue, 2018-2029, (US$ Million)
Figure 47. By Company, South Korea TCR Based Therapy Market Share, 2018-2023
Figure 48. By Type, South Korea TCR Based Therapy Revenue Market Share, 2022 VS 2029
Figure 49. By Application, South Korea TCR Based Therapy Revenue Market Share, 2022 VS 2029
Figure 50. Southeast Asia TCR Based Therapy Revenue, 2018-2029, (US$ Million)
Figure 51. By Company, Southeast Asia TCR Based Therapy Market Share, 2018-2023
Figure 52. By Type, Southeast Asia TCR Based Therapy Revenue Market Share, 2022 VS 2029
Figure 53. By Application, Southeast Asia TCR Based Therapy Revenue Market Share, 2022 VS 2029
Figure 54. India TCR Based Therapy Revenue, 2018-2029, (US$ Million)
Figure 55. By Company, India TCR Based Therapy Market Share, 2018-2023
Figure 56. By Type, India TCR Based Therapy Revenue Market Share, 2022 VS 2029
Figure 57. By Application, India TCR Based Therapy Revenue Market Share, 2022 VS 2029
Fi
Research Methodology:
TCR Based Therapy Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|